The statistical analysis of mortality rates in carriers and non‐carriers indicates that individuals with HLA‐A*23 and HLA‐DRB1*10 have significantly higher fatality rates after infection with COVID‐19. This evidence concerns the gene HLA-DRB1 and infection.